Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects [Phase 1, Phase 2]

View source ↗

Summary

Clinical study evaluating the safety and efficacy of BinD19 in childhood relapsed/refractory B-cell ALL and lymphoma (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia Childhood
• B-cell Lymphoma Childhood

Drugs mentioned

• BinD19

Snippet

Sponsor: Shenzhen BinDeBio Ltd. | Conditions: Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood, Refractory B-cell Acute Lymphoblastic Leukemia, Childhood | Phase 1, Phase 2 | Status: UNKNOWN